
Xtant Medical Holdings, Inc.: updates and filings
Price
$0.21
November 17, 2026Market cap $29M
What Ploutos Investor adds for Xtant Medical
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from 2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 16, 2026next Feb 11, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
March 2026
January 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 16, 2026Results of operationsForm8-K
- Aug 11, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 11, 2026Results of operationsForm8-K
- Aug 7, 2026Shareholder voteForm8-K
- Jun 23, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Jun 23, 2026Additional annual meeting materialFormDEFA14A
- Jun 23, 2026Annual meeting proxy statementFormDEF 14A
- May 29, 2026Conflict minerals reportFormSD
- May 13, 2026FilingFormS-8 POS
- May 13, 2026FilingFormS-8 POS
- May 13, 2026FilingFormS-8 POS
- May 13, 2026FilingFormS-8 POS
- May 13, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 13, 2026Results of operations, other material eventsForm8-K
- Apr 13, 2026Regulation FD disclosure, other material eventsForm8-K
- Mar 31, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 31, 2026Results of operationsForm8-K
- Mar 2, 2026Other material eventsForm8-K
- Feb 17, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 16, 2026Other material eventsForm8-K
- Dec 3, 2025Acquisition or disposal of assets, event accelerating an obligation, Regulation FD disclosureForm8-K
- Nov 10, 2025Shares registered for employeesFormS-8
- Nov 10, 2025Results of operationsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 16, 2026 | 8-K | Results of operations | Document |
| Aug 11, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 11, 2026 | 8-K | Results of operations | Document |
| Aug 7, 2026 | 8-K | Shareholder vote | Document |
| Jun 23, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Jun 23, 2026 | DEFA14A | Additional annual meeting material | Document |
| Jun 23, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| May 29, 2026 | SD | Conflict minerals report | Document |
| May 13, 2026 | S-8 POS | Filing | Document |
| May 13, 2026 | S-8 POS | Filing | Document |
| May 13, 2026 | S-8 POS | Filing | Document |
| May 13, 2026 | S-8 POS | Filing | Document |
| May 13, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 13, 2026 | 8-K | Results of operations, other material events | Document |
| Apr 13, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Mar 31, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 31, 2026 | 8-K | Results of operations | Document |
| Mar 2, 2026 | 8-K | Other material events | Document |
| Feb 17, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 16, 2026 | 8-K | Other material events | Document |
| Dec 3, 2025 | 8-K | Acquisition or disposal of assets, event accelerating an obligation, Regulation FD disclosure | Document |
| Nov 10, 2025 | S-8 | Shares registered for employees | Document |
| Nov 10, 2025 | 8-K | Results of operations | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 6, 2009.
The full analysis
What do Xtant Medical's filings show?
The filings are where every one of Xtant Medical's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.